BofA Pharma Bus Tour - Global
Skip to main content
Ipsen Home Page
Press shift tab to select search category
Loading...
  • Newsroom arrow down
      < Back
    • Newsroom
    • Press Releases
    • Media Updates
    • Media Resources
    • Contacts
    • Subscribe
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports & Regulated Information
    • Investor Events & Financial Calendar
    • Shareholder Information
    • Subscribe
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
    • Job Search
  • Contacts arrow down
      < Back
    • Contacts
    • Contacts
    • Our Locations
    • Report Side Effects
    • Subscribe
  • Press shift tab to select search category
    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  •  Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
    • UAE & Gulf
  • Home
  • Company
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Expertise
      < Back
    • Expertise
    • Oncology
    • Rare Disease
    • Neuroscience
    • Medicines
  • Science
      < Back
    • Science
    • Science
        < Back
      • Science
      • Oncology
      • Rare Disease
      • Neuroscience
    • Profiles
    • Partnering
        < Back
      • Partnering
      • Therapeutic focus
      • Meet the team
    • Clinical Trials
        < Back
      • Clinical Trials
      • Lay Summaries
      • Find Clinical Trials
    • Pipeline
  • Sustainability
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patients
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Collaborate with us
  • Stories
  1. Home
  2. Events
  3. Investor Event events

BofA Pharma Bus Tour

Post navigation

Previous
Next

BofA Pharma Bus Tour

Speakers

Aymeric Le Chatelier

Aymeric Le Chatelier

Executive Vice President

Chief Financial Officer

BofA Pharma Bus Tour

- 11 March 2026 - 0 mins read

Speakers

Aymeric Le Chatelier

Aymeric Le Chatelier

Executive Vice President

Chief Financial Officer

Post navigation

Previous
Next
Share this on social media
  • Share on LinkedIn
  • Share on Facebook
  • Share on Email

Related Events

Jefferies Healthcare Conference
17 November 2026 0 mins read

Jefferies Healthcare Conference
UBS London
10 November 2026 0 mins read

UBS London
Exane Bus Tour
09 September 2026 0 mins read

Exane Bus Tour
Morgan Stanley Healthcare Conference
08 September 2026 0 mins read

Morgan Stanley Healthcare Conference
Wells Fargo Healthcare Conference
04 September 2026 0 mins read

Wells Fargo Healthcare Conference
Portzamparc Mid & Small Caps Conference
25 June 2026 0 mins read

Portzamparc Mid & Small Caps Conference
TD Cowen Bus Tour
24 June 2026 0 mins read

TD Cowen Bus Tour
J.P.Morgan European Healthcare Forum
18 June 2026 0 mins read

J.P.Morgan European Healthcare Forum
Jefferies Pan-European Mid-Cap Conference
25 March 2026 0 mins read

Jefferies Pan-European Mid-Cap Conference
Jefferies Healthcare Conference
02 June 2026 0 mins read

Jefferies Healthcare Conference

IPN price

€164.40

 €-0.70 (-0.42%)

  • Media Resources
  • Annual Report
  • Contacts
  • Our Locations
Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

© Ipsen Pharma. All rights reserved - 2026

You are now leaving the Ipsen group website. To continue, please click on Continue?

Continue